Liver tests, cardiovascular outcomes and effects of empagliflozin in patients with heart failure and preserved ejection fraction: The EMPEROR‐Preserved trial.
Saved in:
| Title: | Liver tests, cardiovascular outcomes and effects of empagliflozin in patients with heart failure and preserved ejection fraction: The EMPEROR‐Preserved trial. |
|---|---|
| Authors: | Böhm, Michael1,2 (AUTHOR) michael.boehm@uks.eu, Butler, Javed3,4 (AUTHOR), Krawczyk, Marcin5 (AUTHOR), Mahfoud, Felix1 (AUTHOR), Haring, Bernhard1,2 (AUTHOR), Filippatos, Gerasimos6 (AUTHOR), Ferreira, João Pedro7,8,9 (AUTHOR), Pocock, Stuart J.10 (AUTHOR), Brueckmann, Martina11,12 (AUTHOR), Ofstad, Anne Pernille13,14 (AUTHOR), Schüler, Elke15 (AUTHOR), Wanner, Christoph16 (AUTHOR), Verma, Subodh17 (AUTHOR), Packer, Milton18,19 (AUTHOR), Anker, Stefan D.20 (AUTHOR) |
| Source: | European Journal of Heart Failure. Aug2023, Vol. 25 Issue 8, p1375-1383. 9p. 7 Graphs. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 13889842 |
|---|---|
| DOI: | 10.1002/ejhf.2922 |
